Covered recipient · General Payments record
JILLIAN RISA GORO
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2022–2024
$355.21
- Reported across 19 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $311.18 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $51.47 | 3 |
| SANOFI-AVENTIS U.S. LLC | $49.11 | 2 |
| Lilly USA, LLC | $48.18 | 3 |
| Novo Nordisk AS | $45.98 | 3 |
| Amgen Inc. | $42.42 | 3 |
| ViiV Healthcare Company | $20.10 | 1 |
| GlaxoSmithKline, LLC. | $19.89 | 1 |
| PFIZER INC. | $19.57 | 1 |
| DEXCOM, INC. | $14.46 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $15.16 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117565678 | CMS |
| Amgen Inc. | $13.89 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117565680 | CMS |
| Amgen Inc. | $13.37 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117565682 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.86 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104476050 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.88 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104479346 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.73 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105439292 | CMS |
| Dexcom, Inc. | $14.46 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153367107 | CMS |
| GlaxoSmithKline, LLC. | $19.89 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116008748 | CMS |
| Lilly USA, LLC | $19.22 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135707682 | CMS |
| Lilly USA, LLC | $13.70 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135722305 | CMS |
| Lilly USA, LLC | $15.26 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135645797 | CMS |
| Novo Nordisk Inc | $13.32 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100631841 | CMS |
| Novo Nordisk Inc | $14.47 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100463024 | CMS |
| Novo Nordisk Inc | $18.19 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100279864 | CMS |
| PFIZER INC. | $19.57 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131875413 | CMS |
| SANOFI-AVENTIS U.S. LLC | $20.50 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140007260 | CMS |
| SANOFI-AVENTIS U.S. LLC | $28.61 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140007264 | CMS |
| ViiV Healthcare Company | $20.10 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1112806777 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.